tiprankstipranks
Advertisement
Advertisement

ARWR Stock Latest News

Arrowhead’s ARO-C3 Kidney Trial Reaches Completion, Setting Up the Next Catalyst for ARWR Investors
Company AnnouncementsArrowhead’s ARO-C3 Kidney Trial Reaches Completion, Setting Up the Next Catalyst for ARWR Investors
2d ago
ARWR
Arrowhead’s ARO-CFB Kidney Trial Completion: What Investors Should Watch Next
PremiumCompany Announcements
Arrowhead’s ARO-CFB Kidney Trial Completion: What Investors Should Watch Next
4d ago
ARWR
Arrowhead price target raised to $46 from $35 at Bernstein
PremiumThe Fly
Arrowhead price target raised to $46 from $35 at Bernstein
11d ago
ARWR
Arrowhead Pharmaceuticals’ Earnings Call: Launch, Losses, Bets
PremiumCompany Announcements
Arrowhead Pharmaceuticals’ Earnings Call: Launch, Losses, Bets
16d ago
ARWR
Arrowhead price target raised to $90 from $80 at Chardan
PremiumThe Fly
Arrowhead price target raised to $90 from $80 at Chardan
16d ago
ARWR
Arrowhead reports Q2 EPS (93c), consensus ($1.11)
PremiumThe FlyArrowhead reports Q2 EPS (93c), consensus ($1.11)
17d ago
ARWR
Arrowhead announces exclusive worldwide license agreement with Madrigal Pharma
Premium
The Fly
Arrowhead announces exclusive worldwide license agreement with Madrigal Pharma
19d ago
ARWR
MDGL
Is ARWR a Buy, Before Earnings?
Premium
Pre-Earnings
Is ARWR a Buy, Before Earnings?
19d ago
ARWR
Arrowhead announces Australian TGA approved Redemplo for FCS
PremiumThe Fly
Arrowhead announces Australian TGA approved Redemplo for FCS
23d ago
ARWR
Arrowhead initiated with an Overweight at JPMorgan
PremiumThe Fly
Arrowhead initiated with an Overweight at JPMorgan
23d ago
ARWR
Arrowhead, Astera, Exxon, Intel, Halliburton Trending With Analysts
PremiumWeekend Updates
Arrowhead, Astera, Exxon, Intel, Halliburton Trending With Analysts
29d ago
HAL
XOM
Arrowhead announces EMA recommended approval of Redemplo
PremiumThe Fly
Arrowhead announces EMA recommended approval of Redemplo
1M ago
ARWR
Intel upgraded, Reddit initiated: Wall Street’s top analyst calls
PremiumThe FlyIntel upgraded, Reddit initiated: Wall Street’s top analyst calls
1M ago
CL
MHK
Arrowhead upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Arrowhead upgraded to Overweight from Equal Weight at Morgan Stanley
1M ago
ARWR
Arrowhead price target raised to $93 from $81 at BofA
Premium
The Fly
Arrowhead price target raised to $93 from $81 at BofA
1M ago
ARWR
Arrowhead presents long-term efficacy, safety data for plozasiran
PremiumThe Fly
Arrowhead presents long-term efficacy, safety data for plozasiran
2M ago
ARWR
Maintaining Buy on Arrowhead: APOC3-Driven Value Unlocked by Shasta-3/4 Amid Obesity Program Uncertainty
PremiumRatings
Maintaining Buy on Arrowhead: APOC3-Driven Value Unlocked by Shasta-3/4 Amid Obesity Program Uncertainty
2M ago
ARWR
Wave data brings questions about Arrowhead ‘back to center stage,’ says Leerink
PremiumThe Fly
Wave data brings questions about Arrowhead ‘back to center stage,’ says Leerink
2M ago
WVE
ARWR
Arrowhead price target lowered to $81 from $84 at BofA
PremiumThe Fly
Arrowhead price target lowered to $81 from $84 at BofA
2M ago
ARWR
IONS
Arrowhead Shareholders Reject Say-on-Pay at 2026 Meeting
PremiumCompany AnnouncementsArrowhead Shareholders Reject Say-on-Pay at 2026 Meeting
2M ago
8K
ARWR
Arrowhead Advances Zodasiran Into Phase 3 HoFH Study, Signaling Long-Term Growth Potential
Premium
Company Announcements
Arrowhead Advances Zodasiran Into Phase 3 HoFH Study, Signaling Long-Term Growth Potential
2M ago
ARWR
Arrowhead Pharmaceuticals Earnings Call Flags Pivotal 2026
Premium
Company Announcements
Arrowhead Pharmaceuticals Earnings Call Flags Pivotal 2026
4M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >